2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$34.80-$0.25 (-0.70%)
Price as of Sep 11, 2026 7:47 PM EDT- $2.5BMarket Cap
- 47.45%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$34.80-$0.25 (-0.70%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.05 | ||
Change | +$1.45 (+4.32%) | ||
Open | $33.91 | ||
High | $35.29 | ||
Low | $33.75 | ||
Previous Close | $33.60 | ||
Volume | 3,796,747 | ||
30-Day Average Volume | 2,073,433 | ||
1-Week Change | -2.34% | ||
1-Month Change | 15.71% | ||
1-Year Change | 47.45% | ||
3-Year Change | 84.47% | ||
5-Year Change | 34.14% | ||
Fundamentals | |||
Shares Outstanding | 72.1M | ||
Total Assets | $533.0M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | -$247,000.00 | ||
Net Income | -$109.5M | ||
Free Cash Flow | -$100.3M | ||
EBIT | -$109.5M | ||
EBITDA | -$109.3M | ||
Net Working Capital | $479.2M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | -10,333 | ||
P/B | 6 | ||
P/E | -23 | ||
PEG | -2 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue